Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Duncan Porter

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Clinical and Experimental Rheumatology|October 20, 2012
Intensive management of early rheumatoid arthritis: the TICORA and TEAR studiesDuncan Porter
Best Practice & Research. Clinical Rheumatology|August 25, 2010
Pharmacotherapy: concepts of pathogenesis and emerging treatments. Optimising the strategy of care in early rheumatoid arthritisJames Dale, Duncan Porter
Annals of the Rheumatic Diseases|November 20, 2013
How low to aim in rheumatoid arthritis? Learning from other disciplinesDuncan Porter, James Dale, Naveed Sattar
Annals of the Rheumatic Diseases|July 24, 2020
Classification criteria: time for a rethink?Duncan Porter, Neil Basu, Stefan Siebert
Arthritis & Rheumatology (Hoboken, N.J.)|March 1, 2017
Editorial: Choosing New Targets for Rheumatoid Arthritis Therapeutics: Too Interesting to Fail?Iain B McInnes, Duncan Porter, Stefan Siebert
Current Medical Research and Opinion|August 9, 2008
UK cost-utility analysis of rituximab in patients with rheumatoid arthritis that failed to respond adequately to a biologic disease-modifying antirheumatic drugAdrian Kielhorn, Duncan Porter, Alexander Diamantopoulos, et al.
Arthritis Care & Research|July 10, 2013
Functionally optimized orthoses for early rheumatoid arthritis foot disease: a study of mechanisms and patient experienceKellie S Gibson, James Woodburn, Duncan Porter, et al.
International Journal of Rheumatology|December 6, 2013
Long-Term Drug Survival of TNF Inhibitor Therapy in RA Patients: A Systematic Review of European National Drug RegistersAnamika Arora, Anadi Mahajan, Dean Spurden, et al.
Arthritis Care & Research|December 31, 2013
Tightening up? Impact of musculoskeletal ultrasound disease activity assessment on early rheumatoid arthritis patients treated using a treat to target strategyJames Dale, David Purves, Alex McConnachie, et al.
RMD Open|November 23, 2023
Time-varying risks of infection in patients as they proceed through the phases of 'pre-RA': results from the Scottish Early RA inception cohortDuncan Porter, Sahil Jain, Evelyn Qian, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Clinical and Experimental Rheumatology|October 20, 2012
Intensive management of early rheumatoid arthritis: the TICORA and TEAR studiesDuncan Porter
Best Practice & Research. Clinical Rheumatology|August 25, 2010
Pharmacotherapy: concepts of pathogenesis and emerging treatments. Optimising the strategy of care in early rheumatoid arthritisJames Dale, Duncan Porter
Annals of the Rheumatic Diseases|November 20, 2013
How low to aim in rheumatoid arthritis? Learning from other disciplinesDuncan Porter, James Dale, Naveed Sattar
Annals of the Rheumatic Diseases|July 24, 2020
Classification criteria: time for a rethink?Duncan Porter, Neil Basu, Stefan Siebert
Arthritis & Rheumatology (Hoboken, N.J.)|March 1, 2017
Editorial: Choosing New Targets for Rheumatoid Arthritis Therapeutics: Too Interesting to Fail?Iain B McInnes, Duncan Porter, Stefan Siebert
Current Medical Research and Opinion|August 9, 2008
UK cost-utility analysis of rituximab in patients with rheumatoid arthritis that failed to respond adequately to a biologic disease-modifying antirheumatic drugAdrian Kielhorn, Duncan Porter, Alexander Diamantopoulos, et al.
Arthritis Care & Research|July 10, 2013
Functionally optimized orthoses for early rheumatoid arthritis foot disease: a study of mechanisms and patient experienceKellie S Gibson, James Woodburn, Duncan Porter, et al.
International Journal of Rheumatology|December 6, 2013
Long-Term Drug Survival of TNF Inhibitor Therapy in RA Patients: A Systematic Review of European National Drug RegistersAnamika Arora, Anadi Mahajan, Dean Spurden, et al.
Arthritis Care & Research|December 31, 2013
Tightening up? Impact of musculoskeletal ultrasound disease activity assessment on early rheumatoid arthritis patients treated using a treat to target strategyJames Dale, David Purves, Alex McConnachie, et al.
RMD Open|November 23, 2023
Time-varying risks of infection in patients as they proceed through the phases of 'pre-RA': results from the Scottish Early RA inception cohortDuncan Porter, Sahil Jain, Evelyn Qian, et al.
Pageof 4